Team:UFMG Brazil

From 2013.igem.org

(Difference between revisions)
Line 6: Line 6:
The main goal is to detect each of these biomarkers using our engineered E. coli by integrating the signals CFP, YFP and RFP produced when BNP, IMA and TMAO, respectively, are present in a sample of patient serum. This diagnosis is based on color intensity of the fluorescent proteins. So, we can establish the presence or absence and severity of ACS disease and predict earlier a myocardial event, thus providing information for fast treatment.
The main goal is to detect each of these biomarkers using our engineered E. coli by integrating the signals CFP, YFP and RFP produced when BNP, IMA and TMAO, respectively, are present in a sample of patient serum. This diagnosis is based on color intensity of the fluorescent proteins. So, we can establish the presence or absence and severity of ACS disease and predict earlier a myocardial event, thus providing information for fast treatment.
<html>
<html>
-
/*
 
-
<script type="text/javascript">
 
-
 
-
image_0 = new Image();
 
-
image_1 = new Image();
 
-
image_2 = new Image();
 
-
image_3 = new Image();
 
-
 
-
image_0.src = "https://static.igem.org/mediawiki/2013/3/3e/Ufmg_2013_ilustra0.jpg";
 
-
image_1.src = "https://static.igem.org/mediawiki/2013/2/22/Ufmg_2013_ilustra1.jpg";
 
-
image_2.src = "https://static.igem.org/mediawiki/2013/2/2e/Ufmg_2013_ilustra2.jpg";
 
-
image_3.src = "https://static.igem.org/mediawiki/2013/0/09/Ufmg_2013_ilustra3.jpg";
 
-
 
-
function change_schema_image(img)
 
-
{
 
-
  schema_img=document.getElementById("schema_img");
 
-
  schema_img.src = img.src;
 
-
}
 
-
</script>
 
-
 
-
<center><img src="https://static.igem.org/mediawiki/2013/3/3e/Ufmg_2013_ilustra0.jpg" usemap="#schema_map" id="schema_img"></center>
 
-
 
-
<map name="schema_map">
 
-
<area shape="rect" coords="360,120,450,170" onmouseover="change_schema_image(image_0)">
 
-
<area shape="rect" coords="360,170,450,230" onmouseover="change_schema_image(image_1)">
 
-
<area shape="rect" coords="360,250,450,310" onmouseover="change_schema_image(image_2)">
 
-
<area shape="rect" coords="360,300,450,360" onmouseover="change_schema_image(image_3)">
 
-
</map>
 
-
*/
 
<center><iframe width="790px" height="430px" src="https://2013.igem.org/Team:UFMG_Brazil/homeimg" frameborder=0 name="quadro" scrolling = "no"></iframe></center>
<center><iframe width="790px" height="430px" src="https://2013.igem.org/Team:UFMG_Brazil/homeimg" frameborder=0 name="quadro" scrolling = "no"></iframe></center>
-
 
</html>
</html>
{{Team:UFMG Brazil/sponsor}}
{{Team:UFMG Brazil/sponsor}}

Revision as of 20:17, 27 September 2013

Death by heart diseases is very common worldwide, being Acute Coronary Syndrome (ACS) its main cause. This fact is deeply related to late diagnosis, which is usually made after the cardiac event had already occurred. We, from UFMG team, decided to explore this problem building a system capable of providing a precocious diagnosis for ACS based in 3 biomarkers:

  • Brain Natriuretic Peptide (BNP),
  • Trimethylamine-N-Oxide (TMAO),
  • Ischemia Modified Albumin (IMA).

The main goal is to detect each of these biomarkers using our engineered E. coli by integrating the signals CFP, YFP and RFP produced when BNP, IMA and TMAO, respectively, are present in a sample of patient serum. This diagnosis is based on color intensity of the fluorescent proteins. So, we can establish the presence or absence and severity of ACS disease and predict earlier a myocardial event, thus providing information for fast treatment.

Our Sponsors

Reitoria-de-pesquisa-UFMG.jpg Reitoria-de-posgraduacao-UFMG.jpg Icb ufmg.jpg Bioquimica.jpg Bioinformatica.jpg INCT.jpg Inctv.jpg Nanobiofar.jpg Fapemig.jpg Sintesebiotecnologia.jpg

Retrieved from "http://2013.igem.org/Team:UFMG_Brazil"